Sevelamer Carbonate Tablet
Product Images NDC 64380-872

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 64380-872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (6566b265 1cda 4f44 90c7 C2572591791a 01)

Chemical structure diagram showing the polymeric structure of sevelamer carbonate, including ammonium groups (NH3+, NH2) and bicarbonate (HCO3-) ions, illustrating its complex arrangement as found in the active ingredient of Sevelamer Carbonate tablets.*

FDA Label Image

Figure-2 (6566b265 1cda 4f44 90c7 C2572591791a 02)

A forest plot chart depicting subgroup analysis results comparing Sevelamer Carbonate and placebo. The vertical axis lists subgroups by screening body surface area, baseline serum phosphorus, age, and dialysis status. The horizontal axis shows effect size differences favoring either Sevelamer Carbonate or placebo, with confidence intervals for each subgroup.*

FDA Label Image

Figure 2 (6566b265 1cda 4f44 90c7 C2572591791a 03)

A cumulative distribution plot comparing the percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL). The graph contrasts results for sevelamer hydrochloride and an active control, with the x-axis showing reduction in serum phosphorus from worsened increase to improved reduction, and the y-axis showing the percentage of patients with reduction greater than or equal to specific values.*

FDA Label Image

Image (6566b265 1cda 4f44 90c7 C2572591791a 04)

Line graph depicting phosphorus change from baseline over a 52-week study period comparing Sevelamer Hydrochloride and an active control. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change ranging from -5 to 2. Both treatments show a rapid decrease in phosphorus initially, stabilizing around -2 to -3 for the remainder of the study.*

FDA Label Image

Container Label 270s (6566b265 1cda 4f44 90c7 C2572591791a 05)

Label for Sevelamer Carbonate Tablets, 800 mg, oral film-coated tablets with a count of 270. The label lists the active ingredient as sevelamer carbonate 800 mg and several inactive ingredients. It includes storage instructions, dosage note to see package insert, and identifies the manufacturer as Strides Pharma Science Ltd., India, with distribution by Strides Pharma Inc., Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.